UCT spin-off receives millions in European funding UCT News

Cape Bio Pharms, a biotech company with roots in the University of Cape Town’s (UCT) Biopharming Research Unit (BRU), has received a multimillion-rand capital injection to fast-track the production of affordable plant-based rapid diagnostic COVID-19 test kits.

UCT spin-off receives millions in European funding UCT News

You may also like

ISPMF NEWSLETTER

ISPMF NEWSLETTER

Covid Related Work By ISPMF Members

Watch Video
Prof Rybicki named UCT’s most prolific inventor

Prof Rybicki named UCT’s most prolific inventor

Prof Edward Rybicki has been recognised as the University of Cape Town’s most prolific inventor

Watch Video